Projects per year
Search results
-
Finished
IMbrave050: A phase III, multicentre, randomized, open-label study of atezolizumab (anti-PD-L1 antibody) plus bevacizumab plus bevacizumab versus active surveillance as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after surgical resection or ablationR SURGICAL RESECTION OR ABLATION
Poursoltan, P., Chapman, N. & Parshionikar, A.
11/12/19 → 30/09/24
Project: Other
-
DYNAMIC III: Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study
Poursoltan, P., Chapman, N. & Cunningham, J.
2/05/19 → 1/05/24
Project: Other
-
Phase Ib/II Study of Intra-Arterial Liver Isolation Chemotherapy in Patients with Hepatic Metastases from Colorectal Cancer
Poursoltan, P., Butala, R. & Cunningham, J.
30/04/19 → 4/12/23
Project: Research